Compare Stocks

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. The company was incorporated in 1982 and is headquartered in Tucson, Arizona.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

HORIBA, Ltd. manufactures and sells instruments and systems worldwide. The company operates in five segments: Automotive, Environment/Process, Medical, Semiconductor, and Scientific. The Automotive segment offers engine emission measurement devices; in-use vehicle emission measurement devices; on-board emission measurement devices; in-vehicle exhaust gas measuring devices; driveline test systems; engine test systems; brake test systems; fuel cell test devices; battery test devices; and vehicle development engineering and test engineering services, as well as leases and manages research and development facilities. The Environment/Process segment provides flue gas analyzers, water quality measuring devices, air pollution monitoring analyzers, environmental radiation measuring instruments, and process measurement equipment. The Medical segment offers hematology and CRP, immunology, clinical chemistry, and blood glucose analyzers, blood cell counters, biochemical testing devices, blood glucose testing devices, as well as coagulation/hemostasis analyzers. The Semiconductor segment provides mass flow controllers, chemical concentration monitors, semiconductor contaminant inspection equipment, and residual gas analyzer. The Scientific segment offers Raman spectrometers, pH meters, water quality measuring devices, particle size distribution measuring devices, X -ray fluorescence analyzers, elemental analyzers, fluorescence spectroscopy/lifetime measurement devices, spectrometer/detectors, and gratings. It also engages in the fund management, software development, and automation software for engine. The company's products are used in arts, entertainment, and recreation; education, research and development, and government institution; food and beverage; energy and environment; health care; industrials; information technology; water; materials; mobility and transport; and waste management applications. HORIBA, Ltd. was founded in 1945 and is headquartered in Kyoto, Japan.

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.